Lv11
10 积分 2024-07-16 加入
Bruton’s Tyrosine Kinase Inhibitors: Recent Updates
5小时前
已完结
Advances in Primary Central Nervous System Lymphoma
6小时前
已完结
Survival outcomes and treatment experience of 124 patients with primary central nervous system lymphoma
1个月前
已完结
Clinicopathological risk factors for prognosis and therapeutic response of primary central nervous system lymphoma in China: a single-center retrospective analysis of 118 cases
1个月前
已完结
Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults
2个月前
已完结
Epigenetic agents plus anti-PD-1 reshapes tumor microenvironment and restores antitumor efficacy in Hodgkin lymphoma
3个月前
已完结
Epigenetic agents plus anti-PD-1 reshapes tumor microenvironment and restores antitumor efficacy in Hodgkin lymphoma
3个月前
已关闭
Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)
6个月前
已关闭
Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)
6个月前
已关闭
Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities
9个月前
已完结
皖公网安备34019202002308
